While the use of receptor biomarkers in the diagnosis and treatment of breast cancer has proved extraordinarily useful, perhaps it is time to consider adding routine measurement of ACSL4 protein as a predictive indicator in the management of breast cancer. The gene discussed is ACSL4; the disease is breast carcinoma.